Woodline Partners’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.5M | Buy |
2,608,372
+1,607,523
| +161% | +$37.9M | 0.32% | 71 |
|
|
2025
Q1 | $24M | Sell |
1,000,849
-201,617
| -17% | -$4.84M | 0.16% | 191 |
|
|
2024
Q4 | $50.9M | Buy |
1,202,466
+201,573
| +20% | +$8.52M | 0.34% | 79 |
|
|
2024
Q3 | $44.2M | Buy |
1,000,893
+51,976
| +5% | +$2.3M | 0.37% | 79 |
|
|
2024
Q2 | $34.3M | Buy |
948,917
+1,820
| +0.2% | +$65.8K | 0.33% | 86 |
|
|
2024
Q1 | $40.8M | Sell |
947,097
-1,560,043
| -62% | -$67.3M | 0.38% | 78 |
|
|
2023
Q4 | $38.6M | Sell |
2,507,140
-55,460
| -2% | -$853K | 0.42% | 67 |
|
|
2023
Q3 | $35.1M | Buy |
2,562,600
+808,910
| +46% | +$11.1M | 0.41% | 56 |
|
|
2023
Q2 | $28.1M | Buy |
1,753,690
+972
| +0.1% | +$15.6K | 0.33% | 90 |
|
|
2023
Q1 | $13.6M | Buy |
1,752,718
+1,603,165
| +1,072% | +$12.4M | 0.19% | 157 |
|
|
2022
Q4 | $2.89M | Sell |
149,553
-19,724
| -12% | -$382K | 0.04% | 420 |
|
|
2022
Q3 | $3.61M | Buy |
+169,277
| New | +$3.61M | 0.05% | 353 |
|